Clinical Trial Update: Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment [Phase 4]

View source ↗

Summary

Phase 4 post-marketing study evaluating the effect of gabapentin enacarbil in Restless Legs Syndrome patients with moderate renal impairment; study status compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• gabapentin enacarbil (gabapentin enacarbil)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Restless Legs Syndrome (RLS) | Phase 4 | Status: COMPLETED